Novel Soluable Gamma-Secretase Modulators

2010

Building on in vitro characterization of a novel series of soluable gamma-secretase modulators (SGSMs) funded by Cure Alzheimer’s Fund, the current project is a thorough pharmacological or in vivo examination of these molecules to identify the best or “lead” drug candidate.


Funding to Date

$250,000

Focus

Drug Discovery

Researchers

Rudolph Tanzi, Ph.D.


Steven L. Wagner, Ph.D.